INSIGHTS ON QUALITY CONTROL

• Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres

  Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.

• Curia's Approach To Regulatory Compliance In Korea

  Navigating Asian pharma markets requires alignment with local regulations. Standardized documentation, facility registrations, and strong quality systems support compliance and reliable supply.

   

• LYO Cycle Development Ensures Success For Oncology Drug Scale-Up

  An optimized lyophilization cycle removes excess moisture during scale‑up by adjusting drying for larger equipment, improving stability, maintaining efficiency, and supporting clinical validation.

• Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline

  Meeting tight launch timelines requires more than speed. Smart kit design, controlled production workflows, and scalable processes come together to deliver complex packaging programs quickly.

• Development Of Separation Methods For GLP-1 Synthetic Peptides

  6/30/2025

  Explore a novel HPLC-UV/MS method for analyzing GLP-1 analogs to address critical challenges in peptide separation, impurity detection, and performance for improved reproducibility.

• The Essential Ingredient For GxP Training Innovation

  6/4/2026

  Advanced learning tools depend entirely on the health of the underlying training matrix. Establish a clean, data-driven framework to reduce compliance risks and recover lost operational hours.

• Tablet Metal Detector For Pharmaceutical & Nutraceutical

  6/16/2026

  Optimize high-speed lines with compact multi-lane checkweighing that monitors twelve channels on one screen, features detachable conveyors, and prevents product jams.

• Doubling Up For Speed In Biomanufacturing

  12/12/2025

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk

  8/20/2026

  Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.